Invasive therapies for symptomatic obstructive hypertrophic cardiomyopathy
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F23%3A10467128" target="_blank" >RIV/00064203:_____/23:10467128 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/23:10467128
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=kItiSmbP8k" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=kItiSmbP8k</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.pcad.2023.08.003" target="_blank" >10.1016/j.pcad.2023.08.003</a>
Alternative languages
Result language
angličtina
Original language name
Invasive therapies for symptomatic obstructive hypertrophic cardiomyopathy
Original language description
Hypertrophic cardiomyopathy (HCM) is a genetic condition with multiple different genetic and clinical phenotypes. As awareness for HCM increases, it is important to also be familiar with potential treatment options for the disease. Treatment of HCM can be divided into two different categories, medical and interventional. Typically for obstructive forms of the disease, in which increased septal hypertrophy, abnormally placed papillary muscles, abnormalities in mitral valve or subvalvular apparatus, lead to dynamic left ventricular outflow tract (LVOT) obstruction, treatment is targeted at decreasing obstructive gradients and therefore symptoms. Medications like beta blockers, calcium channel blockers, disopyramide can often accomplish this. However, in patients with severe obstruction or symptoms refractory to medical therapy, either surgical correction of the LVOT obstruction or percutaneous via alcohol septal ablation, are treatment options. In this review, we will focus on the invasive treatment of hypertrophic obstructive cardiomyopathy .
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Progress in Cardiovascular Diseases
ISSN
0033-0620
e-ISSN
1873-1740
Volume of the periodical
80
Issue of the periodical within the volume
September–October
Country of publishing house
US - UNITED STATES
Number of pages
7
Pages from-to
46-52
UT code for WoS article
001084769100001
EID of the result in the Scopus database
2-s2.0-85169506062